Active-loaded particulate materials for topical administration
EP2583672A1
Nanocrystals and amorphous nanoparticles and method for production of the same by a low energy process
EP2229936A1
Nanonized testosterone formulations for improved bioavailability
EP2218447A1
Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
DE102005053462A1
Gentle method for preparing ultrafine particle suspensions, useful for formulating e.g. pharmaceuticals, cosmetics, foods or pesticides, comprises freezing non-aqueous solution then dispersion of the frozen product
DE102005053862A1
Method and device for producing very fine particles and for coating such particles
DE102005017777A1
Preparation of high fine particle suspension comprises dissolving solid in a solvent, freezing, lyophilizing solid matrix, withdrawing solid matrix from solvent and dispersing in an external phase and applying high power on the dispersion
DE102005011786A1
Process for preparing ultrafine submicron suspensions
DE10065217A1
Transfection complexes (TransoPlex) with reduced toxicity, high physical stability and high transfection efficiency as well as processes for their production
DE10036871A1
Dispersions for the formulation of poorly or poorly soluble active ingredients
CN1372452A
UV radiation reflecting or absorbing agents, protecting against harmfu lUV radiation and reinforcing the natural skin barrier
BR0010823A
Stability adjuvant, optimized biocompatibility (sba) to enhance the humoral and cellular immune response
WO0067728A2
Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
BR0010356A
Drug carrier for controlled administration of active ingredient, prepared from lipid-drug matrix conjugates (ldc particles)
DE10016155A1
Agent with UV radiation absorbing and / or reflecting effect to protect against harmful UV radiation and strengthen the natural skin barrier
DE19964085A1
Particulate solid drug carrier, providing retarded release and high bioavailability, comprising lipid-drug conjugate, e.g. tributyrin as source of cell differentiation inhibitor butyric acid
DE19938371A1
Lipid particles based on matrix comprising solid and liquid lipid, useful in diagnostics and for controlled release of active agents, especially pharmaceuticals
DE19932157A1
Process for the gentle production of ultra-fine microparticles and nanoparticles
